Citrus unshiu peel suppress the metastatic potential of murine melanoma B16F10 cells in vitro and in vivo

The peel of Citrus unshiu Marcow. fruits (CU) has long been used as a traditional medicine that has therapeutic effects against pathogenic diseases, including asthma, vomiting, dyspepsia, blood circulation disorders, and various types of cancer. In this study, we investigated the effect of CU peel on metastatic melanoma, a highly aggressive skin cancer, in B16F10 melanoma cells, and in B16F10 cells inoculated‐C57BL/6 mice. Our results show that ethanol extracts of CU (EECU) inhibited cell growth and increased the apoptotic cells in B16F10 cells. EECU also stimulated the induction of mitochondria‐mediated intrinsic pathway, with reduced mitochondrial membrane potential and increased generation of intracellular reactive oxygen species. Furthermore, EECU suppressed the migration, invasion, and colony formation of B16F10 cells. In addition, the oral administration of EECU reduced serum lactate dehydrogenase activity without weight loss, hepatotoxicity, nor nephrotoxicity in B16F10 cell‐inoculated mice. Moreover, EECU markedly suppressed lung hypertrophy, the number and expression of metastatic tumor nodules, and the expression of inflammatory tumor necrosis factor‐alpha in lung tissue. In conclusion, our findings suggest that the inhibitory effect of EECU on the metastasis of melanoma indicates that it may be regarded as a potential therapeutic herbal drug for melanoma.


| INTRODUCTION
Melanoma is the deadliest skin cancer of melanocytic origin and is a highly aggressive tumor that can metastasize to any organ, including the lungs, liver, bones, and brain (Gray-Schopfer, Wellbrock, & Marais, 2007). Metastatic melanoma is one of the most intractable cancers because of its unique ability to metastasize early and its resistance against conventional treatments (Bhatia, Tykodi, & Thompson, 2009). The incidence and mortality of melanoma have been rapidly increasing over the past decades, and the number of cases is growing faster than those any other kind of solid cancer (Ko, 2017). In fact, melanoma has a very poor prognosis, and survival rate remains at less than 5% within 5 years (Chi et al., 2011). Furthermore, the mean overall survival of patients with unresectable metastatic melanoma is less than 1 year (Mellman, Coukos, & Dranoff, 2011). Clinical management of patients with metastatic melanoma has been restrictive for treatment because of the few targeted chemotherapies and contrasted protocol available to them (McQuade et al., 2018). Chemotherapies targeting general mutations have been developed, such as a serine/threonine protein kinase of rapidly accelerated fibrosarcoma (RAF) family, another crucial signaling molecule of RAS family, and phosphatase and tensin homologue.
However, these drugs have the weakness of inducing resistance and cause unintended side effects and are not fully responsive (Pal, Hunt, Diamond, Elmets, & Afaq, 2016;Villareal, Sato, Matsuyama, & Isoda, 2018). Therefore, there is a growing need to develop new, effective, and safe treatments for metastatic melanoma. In this respect, phytochemicals are coming into the spotlight due to their low cost, low toxicity, and low hostility as dietary supplements (Pal et al., 2016). Experimentally, numerous medical plants and herbal pharmacologically active constituents have been reported to have anticancer, antimetastatic, antiangiogenic, and proapoptotic effects in in vitro and in vivo studies (Shu, Cheung, Khor, Chen, & Kong, 2010;Teiten, Gaascht, Dicato, & Diederich, 2013). Several medical plants and phytochemicals, including Allium sativum, Panax ginseng, Rhus verniciflua, Viscum album, camptochecin, curcumin, and resveratrol, have acceptable clinical evidence that supports their anticancer efficacy (Hosseini & Ghorbani, 2015). Actually, some of the pharmacologically active compounds (i.e., taxol analogues, vinca alkaloids, and podophyllotoxin analogues) isolated from these plants are widely used for chemotherapy for patients with cancer (Saklani & Kutty, 2008).
Moreover, several scientists have reported the anticancer effect of CU. According to the study by Lee et al.,  , fermented extract of CU peel inhibited the growth of human pancreatic cancer cells via the induction of caspase-3 cleavage. In 2011, one study reported CU has an antitumor effect through enhancing immune-mediated cytokines in murine renal carcinoma cells (Lee et al., 2011); Jin et al. (2013) suggested that phytochemicals from CU inhibit cell adhesion and invasion in human breast cancer cells. Our previous studies also clearly demonstrated that water and ethanol extracts of CU peel have anticancer effect via the involvement of reactive oxygen species (ROS)-dependent activation of adenosine monophosphate-activated kinase in human breast cancer MCF-7 cells . In addition, we have recently reported that CU peel induced ROS-mediated apoptosis in human breast carcinoma cells  and human bladder cancer cells (Ahn et al., 2017). Based on these previous studies, it is expected that CU peel will have a positive effect on the prevention of various types of cancer. However, there has been no report on the inhibitory effect of CU peel on the metastasis of melanoma cell in vitro and in vivo. Accordingly, we investigated the effect of CU peel on the metastatic potential of B16F10 cells, known to be malignant melanoma cells that are stable in their metastatic potential, in vitro and in vivo.

| Preparation of 70% ethanol extract of CU peel
The dried peels of CU (100 g, purchased from Dong-eui Korean Medical Center, Busan, Republic of Korea) were ground into fine powder and refluxed with 1 L of 70% ethanol solution by sonication for 24 hr. After filtering through a glass filter funnel, the extract was concentrated with a rotary vacuum evaporator (Buchi Labortechnik, Flawil, Switzerland), followed by lyophilization, and then stored at −80°C.
The freeze-dried powder of ethanol extract of CU (EECU) was dissolved in dimethylsulfoxide (Sigma-Aldrich Chemical Co., St. Louis, MO, USA) to a final concentration of 100 mg/mL, and the stock solution was diluted with a cell culture medium to the desired concentration, prior to use.
Thereafter, the cells were treated with the desired concentrations of EECU of 0, 20, 40, 60, 80, and 100 μg/mL for 24 hr, and the cells were then incubated with 50 μg/mL MTT solution for 2 hr. Formazan crystals were dissolved in dimethylsulfoxide, and the absorbance was measured using a microplate reader (VERSA Max, Molecular Device Co., Sunnyvale, CA, USA) at 540 nm. The morphological changes of cells were visualized with phase-contrast microscope (Axio Aver. A1, Carl Zeiss, Oberkochen, Germany).

| Analysis of apoptosis
The alteration of nuclear morphology in apoptotic cells was assessed by cell-permeable nucleic acid stains, 4′,6′-diamidino-2-phenylindole (DAPI; Sigma-Aldrich Chemical Co., St. Louis, MO, USA). After 24 hr treatment with EECU of 0, 50, and 100 μg/mL, the cells were harvested and fixed with 4% paraformaldehyde for 10 min at room temperature (RT). The fixed cells were washed twice with phosphate-buffered saline (PBS) and stained with 1 μg/mL DAPI solution for 10 min, under light-shielded conditions. The cells were washed twice with PBS, and the fluorescence intensity was observed using a fluorescence microscope (EVOS FL Auto2, Carl Zeiss). The magnitude of apoptosis was measured by flow cytometry using the annexin V-fluorescein isothiocyanate (FITC) Apoptosis detection kit (BD Biosciences, San Diego, CA, USA). In brief, the cells were washed twice with cold PBS and resuspended in 500 μL binding buffer, according to the manufacturer's protocol. The cells were doublestained with FITC-labelled annexin V and propidium iodide (PI) for 20 min in the dark. At least 10,000 cells were acquired for each sample and analyzed using a BD Accuri C6 flow cytometer (BD Biosciences, San Jose, CA, USA).

| Intracellular ROS generation
The production of intracellular ROS was measured by flow cytometer using 2′,7′-dichlorofluorescin diacetate (DCF-DA; Invitrogen) as previously described . Briefly, B16F10 cells were seeded onto 6-well plate at a density of 2 × 10 5 cells and then treated with EECU of 0, 20, 60, and 100 μg/mL. In the last 20 min of treatment, 10 μM DCF-DA was added to the incubated cells in the dark. Following incubation, the cells were washed twice with PBS, and 10,000 cells were analyzed for the amount of intracellular ROS by BD Accuri C6 software in a flow cytometer (BD Biosciences) at 480/520 nm.

| Cell migration and invasion assay
To evaluate cell migration, wound lines in the form of a cross were made by scraping with a plastic 200-μL pipette tip in confluent cells.

| Colony formation assay
After treatment with EECU of 0, 20, and 40 μg/mL for 24 hr, singlecell suspensions of B16F10 cells were placed onto 6-well plates. The cells were incubated for 2 weeks until the formation of colonies. After fixation with 3.7% paraformaldehyde, the colonies were stained with 0.1% crystal violet solution (Sigma-Aldrich Chemical Co.) for 10 min at RT. The stained cells were counted and observed under an inverted microscope (Carl Zeiss).

| Analysis of metalloproteinase activity
The cells were treated with EECU of 0, 20, and 40 μg/mL for 24 hr, and then cell culture supernatants were harvested, to measure the activities of metalloproteinase (MMP)-2 and MMP-9. The activities of MMP-2 and MMP-9 were determined using Biotrak Activity Assay system from Amersham Biosciences (Piscataway, NJ, USA), according to the manufacturer's instructions.

| Western blot analysis
Total protein was extracted from the cells using the Bradford Protein

| Reverse transcription-polymerase chain reaction
Total RNA from B16F10 cells was isolated using TRIzol reagent (Invitrogen), following the protocol of the manufacturer. cDNA was syn-

| Animal and experimental procedures
This study was conducted in accordance with the Guidelines for Ani- week, 28 mice were injected into the tail vein with 3 × 10 5 B16F10 cells per 100 μL PBS (JW Pharmaceutical, Seoul, Korea). At the same time, 16 mice were injected in the same area with PBS ( Figure 4a).
After 1 day of tumor inoculation, B16F10 cell-injected mice were randomly divided into three groups: the B16 + control group (n = 10, 100 μL of distilled water), the B16 + EECU 100 group (n = 8, 100 μL of EECU 100 mg/kg/day), and the B16 + EECU 200 group (n = 8, 100 μL of EECU 200 mg/kg/day). Eighteen PBS-injected mice were also randomly divided into two groups: the normal group (n = 8, 100 μL of distilled water) and the EECU 200 group (n = 8, 200 μL of EECU 200 mg/kg/day). All treatments were administrated orally once per day in the morning for 21 days. Mice were sacrificed at Day 21 after B16F10 melanoma cells injection, and blood was placed in heparinized tubes, centrifuged at 3,000 rpm for 10 min at 4°C, and kept at −80°C for subsequent analysis. After perfusion, organs were immediately surgically excised, including liver, kidney, spleen, lung, and thymus, then weighed, and stored at −80°C.

| Biochemical analysis
Plasma alanine aminotransferase (ALT; ab105134) and aspartate aminotransferase (AST; ab105135) were measured with a colorimetric assay, using reagents from Abcam Inc. (Cambridge, UK). Lactate dehydrogenase (LDH; K726) activity and blood urea nitrogen (BUN; ABIN577679) were analyzed using detection kit according to the manufacturer's instructions, which kits were obtained from BioVision, Inc.

| Histology and immunohistochemistry
Histological analysis was performed as described previously . Lung was fixed in 4% formalin and embedded in paraffin.
The sections of 5 μm thickness were cut by microtome (Leica

| Chromatographic analysis
The phytochemical compositions of EECU were analyzed via highperformance liquid chromatography (HPLC; Agilent 1100 series, Agilent Technologies, San Jose, CA, USA), as previously reported (Kim, Bo, et al., 2018). The column used was an OptimaPak C 18 column (RS Tech Co., Daejeon, Republic of Korea), and ultraviolet spectra, scanning 190 to 400 nm, were recorded for all peaks. Standard samples, including naringin, hesperidin, and nephesperidin, were obtained from Sigma-Aldrich Chemical Co. and dissolved in methanol at 0.15 to 200 μg/mL. The EECU sample was diluted in methanol at 5 mg/mL. Figure 6 and Table 1 show the chromatograms and quantitative results of the HPLC analysis of standard samples and EECU.

| Statistical analysis
All experiments were performed at least three times. Data were analyzed using GraphPad Prism software (version 5.03; GraphPad Software, Inc., La Jolla, CA, USA) and expressed as the mean ± SD.
Differences between groups were assessed using analysis of variance followed by ANOVA-Tukey's post hoc test, and p < .05 was considered to indicate a statistically significant difference.

| EECU induced apoptotic cell death in B16F10 melanoma cells
In order to evaluate the cytotoxicity of EECU, B16F10 cells were incubated with EECU of 0-100 μg/mL for 24 hr, and cell viability was assessed by MTT assay. Figure 1a shows that EECU markedly reduced   To determine whether the cell growth inhibition by EECU was associated with apoptosis induction, we performed flow cytometric analysis and observation of nuclear morphology. The result of DAPI staining showed that the EECU-treated cells observed were typical apoptotic nuclei, revealing nuclear fragmentation, destruction of cell membrane integrity, and chromatin condensation (Figure 1b, bottom). The results of the flow cytometric analysis showed that the percentage of annexin V + /PI − cells and annexin V + /PI + cells was markedly increased in EECUtreated cells in a dose-dependent manner (Figure 1c). In addition, the quantitative results of apoptotic cells showed that EECU induced significant apoptosis of B16F10 cells to 26.65% and 48.19% in 50 and 100 μg/mL, respectively (Figure 1d).

| EECU increased mitochondrial dysfunction in B16F10 melanoma cells
We evaluated the effect of EECU on mitochondrial dysfunction in B16F10 cells. Mitochondrial dysfunction plays a critical role in intrinsic apoptosis pathway, which is involved in a change of the MMP (Δψ m ) and production of ROS (Gross, McDonnell, & Korsmeyer, 1999). Therefore, we assessed the mitochondrial function using JC-1 dye, an indicator of MMP (Δψ m ), by a flow cytometer. The results showed that the loss of MMP (Δψ m ) was significantly increased by EECU treatment compared with control in a concentration-dependent manner (Figures 2a,c, p < .0001). In addition, we evaluated intracellular ROS generation using DCF-DA probe. Figure 2c,e shows the results of flow cytometric analysis, which indicate that the ROS generation gradually increased

| EECU reduced the motility of B16F10 melanoma cells via the inhibition of MMPs expression and activity
To assess the effect of EECU on metastatic activity, we investigated the migration and invasion of B16F10 melanoma cells using wound scratch assay and trans-well system, respectively. Figure  (Middle) Cell invasion assay was evaluated using the trans-well chamber system. B16F10 cells were placed in the upper chamber of trans-well insert, and complement medium supplemented with EECU of 0, 20, and 40 μg/mL was added in the lower chamber, and then cells were incubated for 24 hr. (Bottom) B16F10 cells were exposed to EECU of 0, 20, and 40 μg/mL for 15 days, followed by colony formation assay. Cells were stained with 0.1% crystal violet solution, and visualized colonies were observed under microscope. (b) The mobility of B16F10 cells was calculated for EECU-treated cells, as compared with the nontreated control cells for each experiment in different field. (c) The numbers of invading cells in EECU-treated cells, as compared with the nontreated control cells, for each experiment. (d) Rates of colony formation were detected by microplate reader at 650 nm. The quantitative data are expressed in the bar diagram as the mean ± SD (n = 3). The statistical analyses were conducted using analysis of variance (ANOVA-Tukey's post hoc test) between groups. *** p < .0001 when compared to control. (e) Determination of MMP-2 and MMP-9 enzymatic activity by ELISA assay. Relative activities of MMP-2 and MMP-9 in EECU-treated cells are indicated as -fold of control. The data are expressed as the mean ± SD (n = 3), and the statistical analyses were conducted using analysis of variance (ANOVA-Tukey's post hoc test) between groups. *** p < .0001 when compared with control. (f) mRNA expression of extracellular matrix remodeling-related enzymes by EECU in B16F10 cells. At 24 hr after EECU treatment, total RNA was isolated from cells, and quantitative reverse transcription polymerase chain reaction analysis performed of MMP-2, MMP-9, TIMP-1, and TIMP-2 mRNA expression, using the indicated primers. GAPDH was used as the internal control. (g) Protein expression of ECM remodeling-related enzymes by EECU in B16F10 cells. After the cells were incubated with EECU of 20-100 μg/mL for 24 hr, the cellular protein expression of MMP-2, MMP-9, TIMP-1, and TIMP-2 was measured by Western blot analysis with whole cell lysates [Colour figure can be viewed at wileyonlinelibrary.com] panels of Figure 3a, the colony forming ability of B16F10 cells was markedly decreased by EECU relative to the control, in a concentration-dependent manner. The colony formation was suppressed to 60.33% and 42.67% of control by 20 and 40 μg/mL of EECU, respectively (Figure 3d, p < .0001, compared with control).
These findings suggest that the treatment of EECU decreased mobility and the colony formation of melanoma cells.
Because the degradation of extracellular matrix is an essential step in metastasis formation (Hofmann, Westphal, Van Muijen, & Ruiter, 2000), we investigated whether EECU regulates the activity and expression of matrix MMPs. Figure 3e indicates the activity of MMP-2 substantially decreased to 0.29-fold of control, and as well, 40 μg/mL of EECU significantly repressed the activity of MMP-9 to 0.50-fold of control (p < .0001). In addition, EECU effectively The initial and final body weight did not differ between all the groups ( Figure 4c). Mice were sacrificed at Day 21 of treatment, and their organs were surgically excised. As shown in Figure 4d, the weight of the liver, kidney, spleen, and thymus were not significantly different between all groups, exclusive of lung. The B16F10 cells-injected control mice markedly induced lung hypertrophy (3.00-fold of lung weight in normal, p < .001), whereas it was substantially decreased by EECU 200 mg/kg treatment. Additionally, we performed biochemical analysis of the LDH activity, hepatic, and renal function, including ALT, AST, and BUN. The result of analysis for plasma LDH activity, as the most consistent marker of the aggressive carcinogenesis (Chaube et al., 2015), proposed that the LDH activity was apparently increased to 1,050.25 U/L in B16F10 cells-injected control mice (p < .0001 compared with normal mice). However, the LDH activity was meaningfully decreased by the administration of EECU 200 mg/kg (807.14 U/L, p < .0001 compared with control mice), and its activity was similar to that of the normal mice ( Figure 4e). Meanwhile, we found that the activities of plasma ALT and AST were elevated in 40.00 and 326.88 U/L, respectively, in B16F10 cells-injected control mice, whereas the activities of these enzymes were unchanged, following the administration of EECU (Figure 4f,g). In contrast, the levels of BUN showed no significant differences for all groups (Figure 4h). These results suggest that EECU not only reduced lung hypertrophy, but also LDH activity in B16F10-inoculated mice.
Next, we investigated the effect of EECU on the histopathological alteration of lung metastatic tissue following B16F10 inoculation. The number of metastatic tumor nodules in B16F10-injected control mice was apparently increased in comparison with normal mice visually (Figure 5a), as well as numerically (Figure 5b, 105 ± 13, p < .0001 compared with normal mice). In contrast, the number of metastatic tumor nodules was significantly reduced by the oral administration of EECU in a dose-dependent manner. Similar to the results from the count of metastatic tumor, the results of H&E staining also showed that brown-spotted tumor cells were increased by B16F10 cells inoculation, whereas they were decreased by EECU administration (Figure 5 c). In addition, we evaluated whether EECU could suppress lung inflammation in these mice. Figure 5c shows that TNF-α of lung metastatic tissue was overexpressed in B16F10 cell inoculated mice but completely suppressed in EECU-treated mice. These results clearly demonstrate that EECU could suppress lung metastasis and inflammation.

| The phytochemical compositions of EECU
To identify the bioactive compound of EECU, we further performed HPLC analysis. Figure 6a shows the chromatogram of reference compound, whereas Figure 6b shows the extracted compound HPLC chromatogram of EECU. The chromatograms indicate the presence of flavonoid compounds, namely naringin and hesperidin from EECU, and were detected at 30.32 and 31.72 of retention time, respectively.
Quantitative analysis of these three compounds was conducted; the quantity of hesperidin of (5.61 ± 0.02) μg/mg was higher than of naringin of 2.15 ± 0.02 μg/mg (Table 1). However, neohesperidin, another reference flavonoid, was not detected in EECU.

| DISCUSSION
Apoptosis is well-known as programmed cell death and maintains a healthy balance between cell survival and cell death in an organism as an essential mechanism for maintaining cellular homeostasis (Bold, Termuhlen, & McConkey, 1997). Cancer occurs as a result of a series of genetic alterations, during which a normal cell is transformed into a malignant one that is involved in abnormal growth and the uncontrolled proliferation of cells (Hanahan & Weinberg, 2000). Hence, most chemotherapeutic drugs function by inducing apoptosis in malignant cells so the induction of apoptosis can be a major strategy of cancer therapy (Bold et al., 1997). Based on this situation, we have confirmed in previous studies that CU peel has anticancer efficacy via apoptosis, thus we investigated whether EECU ethanol extracts of CU peel have potential prevention against melanoma in vitro and in vivo. In the present study, we have verified that EECU inhibited cell growth in a dose-dependent manner (Figure 1a). Additionally, EECU markedly increased the percentage of annexin V + /PI − cells and annexin V + /PI + cells (Figure 1c,d). Furthermore, EECU-treated cells showed the typical morphological hallmarks of apoptotic cells, such as nuclear fragmentation, chromatin condensation, nucleus irregularity shape, and cell shrinkage (Figure 1b). These results suggest that the inhibition of cell growth by EECU is associated with the induction of apoptotic cell death in B16F10 melanoma cells and also corresponds with the results of our previous studies that EECU stimulated apoptosis in MCF-7 breast cancer cells  and T24 bladder cancer cells . The intrinsic apoptosis signal pathway is initiated by irreparable genetic damage, oxidative stress, high concentration of cytosolic Ca 2+ , and hypoxia, which converge at the mitochondria (Karp, 2008). This pathway is the result of a mitochondrial dysfunction that includes loss of MMP (Δψ m ), production of ROS, opening of the permeability transition pore, and release of cytochrome c, which is closely regulated by Bcl-2 family (Gross et al., 1999;Wong, 2011). There are two main groups of the Bcl-2 proteins, namely the antiapoptotic proteins (Bcl-2, Bcl-XL, Bcl-W, etc.) and the proapoptotic proteins (Bad, Bax, Bak, Bid, Bik, etc.;Reed, 1997). The release of cytochrome c from the mitochondria to the cytoplasm induces caspase-3 via the formation of apoptosome, which consists of caspase-9, Apaf-1, and cytochrome c (Reed, 1997). Caspase-3 converged both intrinsic and death receptor-initiated extrinsic pathways and degrades various substrate proteins, such as PARP (Decker & Muller, 2002). Downstream caspases induce the cleavage of cytoskeletal proteins, protein kinases, and DNA repair proteins, thus leading to alteration of the cytoskeleton and cell cycle, which contribute to the morphological changes in apoptosis (Ghobrial, Witzig, & Adjei, 2005;Wong, 2011 Figure 2F). These results demonstrate that EECU induced apoptosis through a mitochondria-mediated intrinsic pathway in B16F10 melanoma cells.
Melanoma is a particularly aggressive skin cancer with a high capacity for invasion and metastasis, and resistance to cytotoxic antitumor drugs. This is estimated to be because melanocytes originate from highly motile cells that have enhanced survival properties (Gray-Schopfer et al., 2007). Metastasis is caused by the movement of cancer cells from the primary tumor to target organs, thus blocking cancer cell migration and invasion, which are most important for the treatment of melanoma (Bhatia et al., 2009). Herein, we found EECU suppressed the migration and invasion of B16F10 cells in a dose-dependent manner through the results of wound scratch assay and trans-well assay. In addition, we confirmed EECU also inhibited anchorage-dependent colony formation that is a characteristic of tumor cells and closely related to carcinogenesis (Figure 3a and -3), and the regulation of their expression and/or activation on invasion and migration in many types of tumors has been widely reviewed in vitro and in vivo (Hofmann et al., 2000). In particular, MMP-2 and MMP-9 are well-known to induce cancer progression and the metastasis of melanoma through the degradation of Type IV collagen, which is the major component of the basement membrane (Hofmann et al., 1999). In this regard, we demonstrated that EECU markedly decreased the activity of MMP-2 and MMP-9 ( Figure 3E).
Furthermore, our results proved that EECU induced the downregulated expression of MMP-2 and MMP-9 as well as the upregulated expression of TIMP-1 and TIMP-2 in mRNA and protein levels (Figure 3f,g). Based on these findings, we suggest that EECU promotes an increase of TIMP/MMPs ratio as a critical factor in the regulation of the motility of melanoma cells, which may subsequently lead to the suppression of cell migration and invasion associated metastasis.
Following that, we have reconfirmed the efficacy of EECU in the suppression of metastasis in melanoma-inoculated mice. Interestingly, B16F10 cell has been metastasized specifically to the lung following the injection into the tail vein, and most of the cells have been found in the pulmonary tissue (Fidler, 1973). Therefore, the murine B16F10 melanoma is most accepted as a useful model for metastatic lung

FIGURE 6
The phytochemical compound chromatogram from high-performance liquid (HPL) analysis of ethanol extracts of Citrus unshiu Marcow. fruits (EECU). (a) Three reference components of naringin, hesperidin, and neohesperidin were analyzed using high-performance liquid chromatography (HPLC). (b) The chromatograms from the HPLC analysis of EECU tumor: its application having been used to assess the metastatic mechanisms of melanoma and the development of anticancer therapies (Fidler, 1973;Giavazzi & Decio, 2014). Numerous studies reported the experimental lung or pulmonary metastasis model by B16F10 inoculation in C57BL/6 mice and investigated the efficacy of new anticancer drugs and potential phytochemicals in this murine model (Gautam, Densmore, & Waldrep, 2000;Pal et al., 2016;Siddikuzzaman & Grace, 2012). In the present study, we identified that B16F10 cells-inoculated mice have induced lung hypertrophy and increase of the number and expression of metastatic tumor nodules in lung tissue, whereas these were significantly decreased by the oral administration of EECU (Figures 4D and 5). Additionally, the oral administration of EECU reduced serum LDH activity as the most consistent marker of the aggressive carcinogenesis (Chaube et al., 2015), without weight loss, hepatotoxicity, or nephrotoxicity (Figure 4c,e-h). These results suggest that EECU can be a considerably safe therapeutic medicinal plant for metastatic melanoma through its low toxicity and efficacy in the suppression of metastasis. Moreover, our study also provided that B16F10 inoculation promoted the overexpression of TNF-α in the metastatic region, but was suppressed by EECU ( Figure 5c). It is well-known that inflammation plays principal roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis (Grivennikov, Greten, & Karin, 2010 (Yu, Kortylewski, & Pardoll, 2000). In this respect, our results provide the possibility of EECU suppressing inflammation, a hallmark of cancer contributing to tumor development, and may lead to the inhibition of metastasis in lung cancer.
The bioactive compounds of CU peel are well-known to contain flavonoids, such as naringin, hesperidin, and nobiletin, and the plant cell barrier component and its anticancer effect are also well known (Jin et al., 2013;Kim et al., 2015;Park et al., 2018;Shin, Park, & Shin, 2018). Our previous study reported that water extract of CU peel contained the reference flavonoids (i.e., naringin, hesperidin, and neohesperidin) and had anticancer potential (Kim, Bo, et al., 2018). In common with previous study, in the present study, we identified that EECU contains bioactive flavonoids, including naringin and hesperidin ( Figure 6 and Table 1). Recently, numerous studies reported that naringin and hesperidin have the antimetastatic activity. Aroui et al. reported that naringin suppress cell invasion and adhesion of human glioblastoma U87 cells and U251 cells (Aroui et al., 2015(Aroui et al., , 2016. In addition, naringin have antimetastatic activity in human prostate cancer DU145 cells (Erdogan, Doganlar, Doganlar, & Turkekul, 2018). Furthermore, it is reported that hesperidin has suppressive effect of cell mobility in nonsmall cell lung cancer A549 cells (Xia et al., 2018) and human osteosarcoma MG-63 cells (Du et al., 2018). Yu et al. also demonstrated that hesperin attenuated the epithelial to mesenchymal transition in A549 cells (Yu, Li, Ren, & Shen, 2016). Based on these previously studies, the anticancer effect of EECU in melanoma cells and metastatic lung cancer is believed to be attributed to various bioactive compounds, including flavonoids from EECU.
In summary, EECU inhibited cell growth through the induction of mitochondria-mediated intrinsic apoptosis pathway in B16F10 melanoma cells. EECU also promoted down-regulation of MMPs activity and expression, which is a critical factor in the regulation of the motility of melanoma cells, and may subsequently lead to the suppression of cell migration and invasion-associated metastasis. In the metastatic lung cancer mouse, EECU inhibited lung hypertrophy and metastatic tumor nodule, as well as inflammation in lung tissue without toxicity.
When given orally administration, EECU has anti-inflammatory and antimetastatic activities, which are dose-dependent over a range of 100~200 mg/kg. In conclusion, although further studies are necessary to assess the potential clinical use of this plant, or its extract or active principles, our finding suggests the inhibitory effect of EECU on the metastasis of melanoma, and EECU can be considered as a potential therapeutic phytomedicine for melanoma.